Topic Highlight
Copyright ©2012 Baishideng Publishing Group Co.
World J Biol Chem. Jun 26, 2012; 3(6): 110-120
Published online Jun 26, 2012. doi: 10.4331/wjbc.v3.i6.110
Figure 2
Figure 2 Proposed model for regulation of eukaryotic elongation factor 2 by EtOH and human immunodeficiency virus antiretroviral drug lopinavir. EtOH and lopinavir (LPV) increase eukaryotic elongation factor 2 (eEF2) phosphorylation and inactivate this protein. This process is directly mediated by increased AMP-activated protein kinase (AMPK) activity. EtOH reduces eEF2 function owing to decreased protein phosphatase 2A (PP2A) activity, while LPV regulates this process by increasing eEF2 kinase (eEF2K) activity. mTOR: Mammalian target of rapamycin.